Literature DB >> 9584383

Prognosis of osteosarcoma with pulmonary metastases at initial presentation is not dismal.

T Yonemoto1, S Tatezaki, T Ishii, T Satoh, H Kimura, N Iwai.   

Abstract

Prognosis of osteosarcoma has been improved markedly with the introduction of effective, intensive chemotherapy. However, there are many reports that indicate that the prognosis of osteosarcoma with pulmonary metastases at the initial presentation is poor. One hundred seventeen patients with osteosarcoma involving the extremities were treated at the Chiba Cancer Center from 1976 to 1995. Of these, nine (7.6%) patients had pulmonary metastases at initial presentation; these nine patients are the subjects of this article. There was an average of 0.9 pulmonary metastatic lesions at initial presentation seen on plain chest radiographs, an average 2.9 lesions seen on computed tomograms of the chest, and an average 12.7 lesions found at thoracotomy in these nine patients. The pulmonary metastatic lesions that could not be detected by computed tomography of the chest were resected by thoracotomy. Three patients died, and six patients are alive, with the 5-year survival being 64.8%. Intensive chemotherapy and aggressive surgical therapy were done for these patients with osteosarcoma with pulmonary metastases at initial presentation, and it is thought that this improved the prognosis of these patients. Pulmonary metastases of osteosarcoma at initial presentation do not always indicate a hopeless prognosis.

Entities:  

Mesh:

Year:  1998        PMID: 9584383     DOI: 10.1097/00003086-199804000-00024

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

1.  Therapeutic Implications of PPARgamma in Human Osteosarcoma.

Authors:  Eric R Wagner; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qiong Shi; Qing Luo; Xiaoji Luo; Bo Liu; Jinyong Luo; Farbod Rastegar; Connie J He; Yawen Hu; Barrett Boody; Hue H Luu; Tong-Chuan He; Zhong-Liang Deng; Rex C Haydon
Journal:  PPAR Res       Date:  2010-02-16       Impact factor: 4.964

2.  Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival.

Authors:  Darshana D Rasalkar; Winnie C W Chu; Vincent Lee; Bhawan K Paunipagar; Frankie W T Cheng; Chi Kong Li
Journal:  Pediatr Radiol       Date:  2010-09-03

3.  Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma.

Authors:  Jiliang He; Peng Zhang; Qinghu Li; Dongsheng Zhou; Ping Liu
Journal:  Oncol Lett       Date:  2015-11-10       Impact factor: 2.967

4.  6-Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation.

Authors:  Jingzhang Fan; Xin Yang; Zhenggang Bi
Journal:  Tumour Biol       Date:  2014-10-21

5.  Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.

Authors:  Zhenjiang Zhao; Guoguo Jin; Ke Yao; Kangdong Liu; Fangfang Liu; Hanyong Chen; Keke Wang; Dhilli Rao Gorja; Kanamata Reddy; Ann M Bode; Zhiping Guo; Zigang Dong
Journal:  Mol Carcinog       Date:  2019-03-01       Impact factor: 4.784

6.  The metastasectomy and timing of pulmonary metastases on the outcome of osteosarcoma patients.

Authors:  Yu-Min Huang; Chun-Han Hou; Sheng-Mou Hou; Rong-Sen Yang
Journal:  Clin Med Oncol       Date:  2009-09-14

7.  Acriflavine suppresses the growth of human osteosarcoma cells through apoptosis and autophagy.

Authors:  Jingzhang Fan; Xin Yang; Zhenggang Bi
Journal:  Tumour Biol       Date:  2014-06-25

Review 8.  A review of clinical and molecular prognostic factors in osteosarcoma.

Authors:  Jonathan C M Clark; Crispin R Dass; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-27       Impact factor: 4.553

9.  S100A6 expression and function in human osteosarcoma.

Authors:  Xiaoji Luo; Katie A Sharff; Jin Chen; Tong-Chuan He; Hue H Luu
Journal:  Clin Orthop Relat Res       Date:  2008-07-09       Impact factor: 4.176

10.  Establishment and characterization of a new highly metastatic human osteosarcoma cell line.

Authors:  Yuxi Su; Xiaoji Luo; Bai-Cheng He; Yi Wang; Liang Chen; Guo-Wei Zuo; Bo Liu; Yang Bi; Jiayi Huang; Gao-Hui Zhu; Yun He; Quan Kang; Jinyong Luo; Jikun Shen; Jin Chen; Xianqing Jin; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Clin Exp Metastasis       Date:  2009-04-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.